JP2022506955A5 - - Google Patents

Info

Publication number
JP2022506955A5
JP2022506955A5 JP2021525113A JP2021525113A JP2022506955A5 JP 2022506955 A5 JP2022506955 A5 JP 2022506955A5 JP 2021525113 A JP2021525113 A JP 2021525113A JP 2021525113 A JP2021525113 A JP 2021525113A JP 2022506955 A5 JP2022506955 A5 JP 2022506955A5
Authority
JP
Japan
Prior art keywords
lipid nanoparticles
compound
nanoparticles according
approximately
total lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021525113A
Other languages
English (en)
Japanese (ja)
Other versions
JP7506670B2 (ja
JP2022506955A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060595 external-priority patent/WO2020097548A1/en
Publication of JP2022506955A publication Critical patent/JP2022506955A/ja
Publication of JP2022506955A5 publication Critical patent/JP2022506955A5/ja
Application granted granted Critical
Publication of JP7506670B2 publication Critical patent/JP7506670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021525113A 2018-11-09 2019-11-08 脂質ナノ粒子製剤 Active JP7506670B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862758055P 2018-11-09 2018-11-09
US62/758,055 2018-11-09
PCT/US2019/060595 WO2020097548A1 (en) 2018-11-09 2019-11-08 Lipid nanoparticle formulations

Publications (3)

Publication Number Publication Date
JP2022506955A JP2022506955A (ja) 2022-01-17
JP2022506955A5 true JP2022506955A5 (cg-RX-API-DMAC7.html) 2022-11-07
JP7506670B2 JP7506670B2 (ja) 2024-06-26

Family

ID=70612210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021525113A Active JP7506670B2 (ja) 2018-11-09 2019-11-08 脂質ナノ粒子製剤

Country Status (7)

Country Link
US (1) US20220001029A1 (cg-RX-API-DMAC7.html)
EP (1) EP3877522A4 (cg-RX-API-DMAC7.html)
JP (1) JP7506670B2 (cg-RX-API-DMAC7.html)
CN (1) CN113728101A (cg-RX-API-DMAC7.html)
AU (1) AU2019377131A1 (cg-RX-API-DMAC7.html)
CA (1) CA3118559A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020097548A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
CN113286882A (zh) 2018-11-09 2021-08-20 阿布特斯生物制药公司 脂质纳米颗粒制剂
AU2020355000A1 (en) 2019-09-23 2022-03-17 Sepia Therapeutics, Inc. Compositions and methods for modulating apolipoprotein B (APOB) gene expression
CN114729376A (zh) 2019-09-23 2022-07-08 欧米茄治疗公司 用于调节肝细胞核因子4α(HNF4α)基因表达的组合物和方法
WO2021183720A1 (en) 2020-03-11 2021-09-16 Omega Therapeutics, Inc. Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
AU2021252164B2 (en) 2020-04-09 2026-07-02 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
MX2023004371A (es) 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
CN112980878B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac8基因敲除的bhk-21细胞系及其构建方法和应用
CN112877275B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
WO2023283359A2 (en) 2021-07-07 2023-01-12 Omega Therapeutics, Inc. Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
KR20230053998A (ko) 2021-10-15 2023-04-24 (주)지노믹트리 mRNA 발현을 위한 유전자 구조체
CN118804743A (zh) * 2022-03-04 2024-10-18 益杰立科(上海)生物科技有限公司 靶向递送系统和方法
US20260077037A1 (en) * 2022-07-04 2026-03-19 Bharat Biotech International Limited Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof
EP4716741A2 (en) 2023-05-23 2026-04-01 Flagship Labs 114, Inc. Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression
EP4722368A1 (en) 2023-05-26 2026-04-08 Samsung Biologics Co., Ltd. Novel nucleic acid construct comprising poly(a) tail having secondary or tertiary structure and uses thereof
KR20250018367A (ko) 2023-07-28 2025-02-05 한국과학기술원 히스톤 코드 리더 도메인을 포함하는 폴리펩티드 및 이의 용도
KR20250064736A (ko) 2023-11-02 2025-05-12 (주)지노믹트리 방광암 예방 또는 치료용 조성물
AU2024409925A1 (en) 2023-12-26 2026-08-06 Emmune, Inc. Systems for nucleic acid transfer
AU2025217182A1 (en) 2024-02-02 2026-08-06 Editas Medicine, Inc. MODIFIED GUIDE RNAs
WO2025210520A1 (en) * 2024-04-04 2025-10-09 Genevant Sciences Gmbh Lipid nanoparticles for inducing an immunological response
WO2025213138A1 (en) 2024-04-05 2025-10-09 Editas Medicine, Inc. Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma
WO2025264646A2 (en) * 2024-06-17 2025-12-26 The Board Of Regents Of The University Of Texas System Direct in vivo gene editing of lung stem cells for durable therapy of genetic lung disease
CN121265551A (zh) * 2024-07-02 2026-01-06 苏州星核迪赛生物技术有限公司 一种靶向肝实质细胞的核酸递送载体及其应用
WO2026102260A1 (en) 2024-11-08 2026-05-15 Editas Medicine, Inc. Crispr-related methods and compositions targeting angiopoietin like 3 (angptl3)
CN120037202B (zh) * 2025-01-14 2025-12-26 浙江大学 一种基于连接处含有分支结构的阳离子脂质的脂质纳米颗粒及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2621480B1 (en) * 2010-09-30 2018-08-15 Sirna Therapeutics, Inc. Low molecular weight cationic lipids for oligonucleotide delivery
WO2012054365A2 (en) * 2010-10-21 2012-04-26 Merck Sharp & Dohme Corp. Novel low molecular weight cationic lipids for oligonucleotide delivery
US9126966B2 (en) 2011-08-31 2015-09-08 Protiva Biotherapeutics, Inc. Cationic lipids and methods of use thereof
US9352042B2 (en) 2012-02-24 2016-05-31 Protiva Biotherapeutics, Inc. Trialkyl cationic lipids and methods of use thereof
WO2013158579A1 (en) * 2012-04-19 2013-10-24 Merck Sharp & Dohme Corp. Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
WO2015011633A1 (en) * 2013-07-23 2015-01-29 Protiva Biotherapeutics, Inc. Compositions and methods for delivering messenger rna
US10415037B2 (en) * 2014-10-02 2019-09-17 Arbutus Biopharma Corporation Compositions and methods for silencing hepatitis B virus gene expression
AU2017379901B2 (en) 2016-12-21 2024-02-15 Arbutus Biopharma Corporation Methods for ameliorating infusion reactions
CN113286882A (zh) * 2018-11-09 2021-08-20 阿布特斯生物制药公司 脂质纳米颗粒制剂

Similar Documents

Publication Publication Date Title
JP2022506956A5 (cg-RX-API-DMAC7.html)
JP7822173B2 (ja) アルギニノコハク酸合成酵素欠損症のmRNA治療
CN106795096B (zh) 用于递送核酸的新型脂质和脂质纳米颗粒制剂
US12285462B2 (en) pH-triggered membrane peptide-mediated epitope tethering at cell surfaces
JP2022530018A5 (cg-RX-API-DMAC7.html)
CN107922364B (zh) 用于递送核酸的脂质和脂质纳米颗粒制剂
JP2024518375A5 (cg-RX-API-DMAC7.html)
CN107208095B (zh) 用于使乙型肝炎病毒基因表达沉默的组合物和方法
US12351834B2 (en) Compositions and methods for the treatment of ornithine transcarbamylase deficiency
JP7752615B2 (ja) メッセンジャーrnaの直腸送達
Huang et al. An mTOR siRNA‐loaded spermidine/DNA tetrahedron nanoplatform with a synergistic anti‐inflammatory effect on acute lung injury
JP2017536092A5 (cg-RX-API-DMAC7.html)
JP2020532546A (ja) 組織特異的送達用のカチオン性脂質組成物
CN103845317A (zh) 恩他卡朋在预防或治疗肥胖等代谢综合征中的应用
KR20230087536A (ko) Mrna-로딩된 지질 나노입자를 제조하는 개선된 프로세스
EP3908597A1 (en) Composition and methods for treatment of primary ciliary dyskinesia
Chen et al. Aminoguanidine-assembled functional DNA tetrahedron alleviates acute lung injury by targeting the cGAS-STING signaling pathway
ES2331835T3 (es) Oligonucleotidos antisentido capaces de inhibir la formacion de tubos capilares.
CN120754284B (zh) 一种用于肝脏靶向联合递送CRISPR-Cas9系统和单链DNA修复模板的脂质纳米颗粒
EP4267181B1 (en) Nucleic acid stabilizing solution for vaccines, therapy, diagnostics, storage, and transport
US20110081403A1 (en) Histone octamers for increased nucleic acid transfer
US20220220189A1 (en) Compositions and methods for treatment of hemochromatosis
US20220370354A1 (en) Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
JP2025521244A (ja) イオン化可能な脂質およびそれを含むナノ粒子
CN119818705B (zh) 一种mRNA组合物及其应用